162 related articles for article (PubMed ID: 22160619)
1. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study.
Styczynski J; Balduzzi A; Gil L; Labopin M; Hamladji RM; Marktel S; Yesilipek MA; Fagioli F; Ehlert K; Matulova M; Dalle JH; Wachowiak J; Miano M; Messina C; Diaz MA; Vermylen C; Eyrich M; Badell I; Dreger P; Gozdzik J; Hutt D; Rascon J; Dini G; Peters C;
Blood; 2012 Mar; 119(12):2935-42. PubMed ID: 22160619
[TBL] [Abstract][Full Text] [Related]
2. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
3. Young child as a donor of cells for transplantation and lymphocyte based therapies.
Styczynski J
Transfus Apher Sci; 2018 Jun; 57(3):323-330. PubMed ID: 29937306
[TBL] [Abstract][Full Text] [Related]
4. Differences between graft product and donor side effects following bone marrow or stem cell donation.
Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
[TBL] [Abstract][Full Text] [Related]
5. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Shaw BE; Logan BR; Kiefer DM; Chitphakdithai P; Pedersen TL; Abdel-Azim H; Abidi MH; Akpek G; Diaz MA; Artz AS; Dandoy C; Gajewski JL; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Majhail NS; O'Donnell PV; Olsson RF; Savani BN; Schears RM; Stroncek DF; Switzer GE; Williams EP; Wingard JR; Wirk BM; Confer DL; Pulsipher MA
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1830-8. PubMed ID: 26116089
[TBL] [Abstract][Full Text] [Related]
7. Successful tandem transplant in a young aplastic anemia patient from a small-weight 11-month-old sibling donor.
Arora D; Tiwari AK; Dara RC; Misra R; Aggarwal G; Acharya DP; Raina V
Transfus Apher Sci; 2016 Feb; 54(1):144-6. PubMed ID: 26896923
[TBL] [Abstract][Full Text] [Related]
8. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
[TBL] [Abstract][Full Text] [Related]
9. Stem cell mobilization and collection from pediatric patients and healthy children.
Karakukcu M; Unal E
Transfus Apher Sci; 2015 Aug; 53(1):17-22. PubMed ID: 26116046
[TBL] [Abstract][Full Text] [Related]
10. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
[TBL] [Abstract][Full Text] [Related]
11. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Pulsipher MA; Chitphakdithai P; Logan BR; Shaw BE; Wingard JR; Lazarus HM; Waller EK; Seftel M; Stroncek DF; Lopez AM; Maharaj D; Hematti P; O'Donnell PV; Loren AW; Leitman SF; Anderlini P; Goldstein SC; Levine JE; Navarro WH; Miller JP; Confer DL
Blood; 2013 Jan; 121(1):197-206. PubMed ID: 23109243
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
[TBL] [Abstract][Full Text] [Related]
13. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
15. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
16. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
[TBL] [Abstract][Full Text] [Related]
17. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
Yanagisawa R; Hirakawa T; Doki N; Ikegame K; Matsuoka KI; Fukuda T; Nakamae H; Ota S; Hiramoto N; Ishikawa J; Ara T; Tanaka M; Koga Y; Kawakita T; Maruyama Y; Kanda Y; Hino M; Atsuta Y; Yabe H; Tsukada N
Int J Hematol; 2023 Mar; 117(3):421-427. PubMed ID: 36403180
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003.
Pulsipher MA; Levine JE; Hayashi RJ; Chan KW; Anderson P; Duerst R; Osunkwo I; Fisher V; Horn B; Grupp SA
Bone Marrow Transplant; 2005 Feb; 35(4):361-7. PubMed ID: 15608659
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study.
Fauser AA; Basara N; Blau IW; Kiehl MG
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S27-31. PubMed ID: 10933183
[TBL] [Abstract][Full Text] [Related]
20. Immediate and long-term somatic effects, and health-related quality of life of BM donation during early childhood. A single-center report in 210 pediatric donors.
van Walraven SM; Straathof LM; Switzer GE; Lankester A; Korthof ET; Brand A; Ball LM
Bone Marrow Transplant; 2013 Jan; 48(1):40-5. PubMed ID: 22705802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
